Product
JBPOS0101
1 clinical trial
1 indication
Indication
Infantile SpasmsClinical trial
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms PatientsStatus: Terminated, Estimated PCD: 2021-12-10